![]() |
||||
|
||||
|
|
||||
Re: Gyn: Premature Menopause (surgical) and Bioidentical hormones - Re Art's infoFrom: Henry Gregor (henrygregor@yahoo.com)Tue Jan 18 10:27:27 2005
Nicely said, and one can share such info with patients in a non challenging way. For some, any science references may simply be ignored, others may be intellectually open and honest enough to investigate or consider. It's no sin to thank a patient for the oppor'y to have been involved in her care, but if a point has been reached wherein what she requests of you, contradicts what you as a clincician feel is appropriate to your concept of good medicine ...it's not inappropriate to explain to her how you feel. If she cares to corroborate your view with rererence to materials such as Art has provided or via opinions from other practitioners (and you can suggest some respected consultants or refer her to reliable web portals such as WebMD or acog.org, or PubMed) whose tng, skill and knowledge you respect, terrific. If not, accept there's no further benefit for either of you in a continued relatiosnhip. I'd ask her for the same respect for your viewpoint and prerogatives that you are giving to her ...I've found most patients are approachable that way. I'd point out its possible to agree to disagree in an agreable manner, without recriminations. If not, remember the serenity prayer and accept that which one cannot change and move on. Just a viewpoint. Hope the perspective was of some interest. (I've actually had the experience whereby pts and I have parted under such circumstances, and, lol, they've later referred pts to me 'cause they thought the way the situation had been handled was fair and polite.) Hank "art fougner, md" <evsono@pipeline.com> wrote: Caveat emptor. Menopause. 2004 May-Jun;11(3):356-67. Bioidentical hormone therapy: a review. Boothby LA, Doering PL, Kipersztok S. Columbus Regional Drug Information Center, Columbus, GA, USA. lisa.boothby@crhs.net OBJECTIVE: The terms "natural" or "bioidentical" hormone therapy (NHT) are used to describe hormone treatment with individually compounded recipes of certain steroids in various dosage forms, including dehydroepiandrosterone, pregnenolone, testosterone, progesterone, estrone, estradiol, and estriol. Based on the results of a person's salivary hormone levels, the final composition of the compounded dosage form is individualized to that specific person. Proponents claim that NHT is better tolerated than manufactured products. This paper is intended to review the concept of NHT and to determine whether there is sufficient scientific evidence to support its use. DESIGN: A literature search was performed in Medline using the following MeSH terms and key words: drug combinations; progestational hormones; hormone replacement therapy; endometrium; estrogen replacement therapy; climacteric; menopause; estradiol; estrogens; progesterone; drug monitoring; and drug compounding. Current Contents, International Pharmaceutical Abstracts, Cochrane Database of Systematic Reviews, Lexis Nexis, Google, Medscape, MD Consult, and clinicaltrials.gov were searched with key words. RESULTS: There are a few observational studies and clinical trials comparing conventional hormone therapy with bioidentical hormone therapy. Studies generally lacked adequate study design, including small sample sizes and comparison of inequivalent doses, to prove safety and efficacy. Little evidence was found to support individualized hormone dosing based upon saliva hormone concentrations. CONCLUSION: Evidence suggests that, although individualized hormonal products may decrease some symptoms of menopause, it seems they have no proven advantage over conventional hormone therapies and their use is not supported by evidence regarding pharmacokinetics, safety, and efficacy. art
At Mon, 17 Jan 2005, Garry E. Siegel, M.D. wrote:
>
-- art fougner, md
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Sat Aug 2 04:44:50 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.